InspireMD, Inc. — Director's Dealing 2021

Nov 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2021-11-10

Reporting Person: Shore Craig (CFO and CAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-10	Common Stock	A	72978	—	Acquired	118639	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-10	Options to purchase common stock (right to buy)	$4.09	A	24326	Acquired	2031-11-10	Common Stock (24326)	Direct

Footnotes

F1: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.

F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service.